Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
cancer
deals
investing
ipo
2
×
life sciences
national blog main
national top stories
roche
san francisco blog main
san francisco top stories
sanofi
abiraterone
ac immune
acorda therapeutics
aduro biotech
agenus
aldeyra therapeutics
aleksandra rizo
alexion pharmaceuticals
alzheimer's disease
amgen
apalutamide
atypical hemolytic uremic syndrome
bill cassidy
biogen
boulder/denver blog main
boulder/denver top stories
caelum biosciences
cancer drugs
cancer immunotherapy
celgene
chuck grassley
clinical trials
cobimetinib
corvus pharmaceuticals
crenezumab
dengue fever
What
drug
2
×
alzheimer’s
bio
cancer
companies
despite
different
fail
family
gene
hardest
hit
hottest
hunters
increases
ipo
latest
medicines
pharmaceutical
plan
prescription
price
prices
proteins
raise
ras
reels
research
revolution
roundup
start
targets
therapies
typically
year
Language
unset
Current search:
ipo
×
drug
×
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
